NEPH
Price
$3.57
Change
+$0.13 (+3.78%)
Updated
Jul 25 closing price
Capitalization
23.09M
10 days until earnings call
TNDM
Price
$15.89
Change
+$0.45 (+2.91%)
Updated
Jul 25 closing price
Capitalization
2.32B
10 days until earnings call
Interact to see
Advertisement

NEPH vs TNDM

Header iconNEPH vs TNDM Comparison
Open Charts NEPH vs TNDMBanner chart's image
Nephros
Price$3.57
Change+$0.13 (+3.78%)
Volume$22.95K
Capitalization23.09M
Tandem Diabetes Care
Price$15.89
Change+$0.45 (+2.91%)
Volume$1.32M
Capitalization2.32B
NEPH vs TNDM Comparison Chart in %
Loading...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEPH vs. TNDM commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEPH is a Hold and TNDM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (NEPH: $3.57 vs. TNDM: $15.89)
Brand notoriety: NEPH and TNDM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEPH: 49% vs. TNDM: 89%
Market capitalization -- NEPH: $23.09M vs. TNDM: $2.32B
NEPH [@Medical Specialties] is valued at $23.09M. TNDM’s [@Medical Specialties] market capitalization is $2.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEPH’s FA Score shows that 0 FA rating(s) are green whileTNDM’s FA Score has 0 green FA rating(s).

  • NEPH’s FA Score: 0 green, 5 red.
  • TNDM’s FA Score: 0 green, 5 red.
According to our system of comparison, NEPH is a better buy in the long-term than TNDM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEPH’s TA Score shows that 3 TA indicator(s) are bullish while TNDM’s TA Score has 5 bullish TA indicator(s).

  • NEPH’s TA Score: 3 bullish, 3 bearish.
  • TNDM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both NEPH and TNDM are a good buy in the short-term.

Price Growth

NEPH (@Medical Specialties) experienced а -2.06% price change this week, while TNDM (@Medical Specialties) price change was +7.58% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

NEPH is expected to report earnings on Nov 06, 2025.

TNDM is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNDM($2.32B) has a higher market cap than NEPH($23.1M). NEPH YTD gains are higher at: 142.857 vs. TNDM (-55.886). NEPH has higher annual earnings (EBITDA): -1.36M vs. TNDM (-196.97M). TNDM has more cash in the bank: 468M vs. NEPH (4.31M). NEPH has less debt than TNDM: NEPH (1.84M) vs TNDM (416M). TNDM has higher revenues than NEPH: TNDM (748M) vs NEPH (14.2M).
NEPHTNDMNEPH / TNDM
Capitalization23.1M2.32B1%
EBITDA-1.36M-196.97M1%
Gain YTD142.857-55.886-256%
P/E RatioN/A666.67-
Revenue14.2M748M2%
Total Cash4.31M468M1%
Total Debt1.84M416M0%
FUNDAMENTALS RATINGS
NEPH vs TNDM: Fundamental Ratings
NEPH
TNDM
OUTLOOK RATING
1..100
7250
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7298
PRICE GROWTH RATING
1..100
3792
P/E GROWTH RATING
1..100
9893
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEPH's Valuation (71) in the null industry is in the same range as TNDM (99) in the Medical Specialties industry. This means that NEPH’s stock grew similarly to TNDM’s over the last 12 months.

NEPH's Profit vs Risk Rating (100) in the null industry is in the same range as TNDM (100) in the Medical Specialties industry. This means that NEPH’s stock grew similarly to TNDM’s over the last 12 months.

NEPH's SMR Rating (72) in the null industry is in the same range as TNDM (98) in the Medical Specialties industry. This means that NEPH’s stock grew similarly to TNDM’s over the last 12 months.

NEPH's Price Growth Rating (37) in the null industry is somewhat better than the same rating for TNDM (92) in the Medical Specialties industry. This means that NEPH’s stock grew somewhat faster than TNDM’s over the last 12 months.

TNDM's P/E Growth Rating (93) in the Medical Specialties industry is in the same range as NEPH (98) in the null industry. This means that TNDM’s stock grew similarly to NEPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEPHTNDM
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPI436.5220.46
+4.92%
Group 1 Automotive
RCKY23.840.50
+2.14%
Rocky Brands
HSY187.123.22
+1.75%
Hershey Company (The)
CVKD11.490.08
+0.70%
Cadrenal Therapeutics Inc
OPK1.37-0.03
-2.14%
OPKO Health

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with SGHT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
+3.78%
SGHT - NEPH
34%
Loosely correlated
-1.97%
GH - NEPH
28%
Poorly correlated
-2.35%
AZTA - NEPH
25%
Poorly correlated
+1.38%
NEO - NEPH
24%
Poorly correlated
-2.02%
TNDM - NEPH
24%
Poorly correlated
+2.91%
More

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with TFX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
+2.91%
TFX - TNDM
45%
Loosely correlated
+0.85%
SHC - TNDM
40%
Loosely correlated
+1.57%
CLPT - TNDM
40%
Loosely correlated
-0.44%
AZTA - TNDM
38%
Loosely correlated
+1.38%
A - TNDM
36%
Loosely correlated
-0.14%
More